Literature DB >> 17579827

Glucose tolerance is negatively associated with circulating progenitor cell levels.

G P Fadini1, L Pucci, R Vanacore, I Baesso, G Penno, A Balbarini, R Di Stefano, R Miccoli, S de Kreutzenberg, A Coracina, A Tiengo, C Agostini, S Del Prato, A Avogaro.   

Abstract

AIMS/HYPOTHESIS: Circulating progenitor cells participate in cardiovascular homeostasis. Depletion of the pool of endothelial progenitor cells (EPCs) is associated with increased cardiovascular risk. Furthermore, EPCs are reduced in the presence of classical risk factors for atherosclerotic disease, including diabetes mellitus. This study was designed to evaluate progenitor cell levels in volunteers with different degrees of glucose tolerance.
METHODS: Cardiovascular parameters and the levels of circulating CD34(+) and CD34(+) kinase insert domain receptor (KDR)(+) cells were determined in 219 middle-aged individuals with no pre-diagnosed alterations in carbohydrate metabolism. Glucose tolerance was determined by fasting and 2 h post-challenge glucose levels, with IFG and IGT considered as pre-diabetic states.
RESULTS: CD34(+) and CD34(+)KDR(+) cells were significantly reduced in individuals who were found to have diabetes mellitus, and were negatively correlated with both fasting and post-challenge glucose in the whole population. While only CD34(+) cells, but not CD34(+)KDR(+) cells, were significantly reduced in pre-diabetic individuals, post-challenge glucose was an independent determinant of the levels of both CD34(+) and CD34(+)KDR(+) cells. CONCLUSIONS/
INTERPRETATION: Glucose tolerance was negatively associated with progenitor cell levels in middle-aged healthy individuals. Depletion of endothelial progenitors with increasing fasting and post-meal glucose may be one cause of the high incidence of cardiovascular damage in individuals with pre-diabetes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17579827     DOI: 10.1007/s00125-007-0732-y

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  46 in total

Review 1.  Therapeutic angiogenesis and vasculogenesis for tissue regeneration.

Authors:  Paolo Madeddu
Journal:  Exp Physiol       Date:  2005-03-18       Impact factor: 2.969

2.  Circulating endothelial progenitors--cells as biomarkers.

Authors:  Anthony Rosenzweig
Journal:  N Engl J Med       Date:  2005-09-08       Impact factor: 91.245

3.  SDF-1 genotype influences insulin-dependent mobilization of adult progenitor cells in type 2 diabetes.

Authors:  Per M Humpert; Renate Neuwirth; Marco J Battista; Olga Voronko; Maximilian von Eynatten; Ilze Konrade; Gottfried Rudofsky; Thoralf Wendt; Andreas Hamann; Michael Morcos; Peter P Nawroth; Angelika Bierhaus
Journal:  Diabetes Care       Date:  2005-04       Impact factor: 19.112

4.  Optimized flow cytometric analysis of endothelial progenitor cells in peripheral blood.

Authors:  Peter Rustemeyer; Werner Wittkowski; Kerstin Jurk; Armin Koller
Journal:  J Immunoassay Immunochem       Date:  2006

Review 5.  Significance of endothelial progenitor cells in subjects with diabetes.

Authors:  Gian Paolo Fadini; Saverio Sartore; Carlo Agostini; Angelo Avogaro
Journal:  Diabetes Care       Date:  2007-02-02       Impact factor: 19.112

6.  Benfotiamine counteracts glucose toxicity effects on endothelial progenitor cell differentiation via Akt/FoxO signaling.

Authors:  Valentina Marchetti; Rossella Menghini; Stefano Rizza; Alessia Vivanti; Tiziana Feccia; Davide Lauro; Akiyoshi Fukamizu; Renato Lauro; Massimo Federici
Journal:  Diabetes       Date:  2006-08       Impact factor: 9.461

7.  Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair.

Authors:  Caroline Schmidt-Lucke; Lothar Rössig; Stephan Fichtlscherer; Mariuca Vasa; Martina Britten; Ulrike Kämper; Stefanie Dimmeler; Andreas M Zeiher
Journal:  Circulation       Date:  2005-05-31       Impact factor: 29.690

8.  Blood glucose and risk of cardiovascular disease in the Asia Pacific region.

Authors:  C M M Lawes; V Parag; D A Bennett; I Suh; T H Lam; G Whitlock; F Barzi; M Woodward
Journal:  Diabetes Care       Date:  2004-12       Impact factor: 19.112

9.  Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria.

Authors: 
Journal:  Arch Intern Med       Date:  2001-02-12

10.  Transplantation of low dose CD34+KDR+ cells promotes vascular and muscular regeneration in ischemic limbs.

Authors:  Paolo Madeddu; Costanza Emanueli; Elvira Pelosi; Maria Bonaria Salis; Anna Maria Cerio; Giuseppina Bonanno; Mariella Patti; Giorgio Stassi; Gianluigi Condorelli; Cesare Peschle
Journal:  FASEB J       Date:  2004-09-02       Impact factor: 5.191

View more
  45 in total

1.  Prior endurance exercise prevents postprandial lipaemia-induced increases in reactive oxygen species in circulating CD31+ cells.

Authors:  Nathan T Jenkins; Rian Q Landers; Sunny R Thakkar; Xiaoxuan Fan; Michael D Brown; Steven J Prior; Espen E Spangenburg; James M Hagberg
Journal:  J Physiol       Date:  2011-09-19       Impact factor: 5.182

2.  Bone marrow-derived cells and the vasculature in diabetes: from biomarker to treatment?

Authors:  N A Hanley
Journal:  Diabetologia       Date:  2007-07-26       Impact factor: 10.122

Review 3.  A reappraisal of the role of circulating (progenitor) cells in the pathobiology of diabetic complications.

Authors:  G P Fadini
Journal:  Diabetologia       Date:  2013-10-31       Impact factor: 10.122

4.  Hematopoietic Progenitor Cell Harvesting Is Feasible after Treatment with Brentuximab Vedotin in CD30(+) Lymphoma Patients Who Received Multiple Prior Lines of Treatment.

Authors:  Manuel Afable; Paolo F Caimi; Chitra Hosing; Marcos de Lima; Issa Khouri; Basem M William; Yago Nieto; Brenda W Cooper; Paolo Anderlini; Stanton L Gerson; Hillard M Lazarus; Richard Champlin; Uday Popat
Journal:  Biol Blood Marrow Transplant       Date:  2015-04-30       Impact factor: 5.742

Review 5.  An underlying principle for the study of circulating progenitor cells in diabetes and its complications.

Authors:  G P Fadini
Journal:  Diabetologia       Date:  2008-07       Impact factor: 10.122

Review 6.  Glucose metabolism, hyperosmotic stress, and reprogramming of somatic cells.

Authors:  Rosalinda Madonna; Aniko Görbe; Peter Ferdinandy; Raffaele De Caterina
Journal:  Mol Biotechnol       Date:  2013-10       Impact factor: 2.695

Review 7.  The promise of cell-based therapies for diabetic complications: challenges and solutions.

Authors:  Yagna P R Jarajapu; Maria B Grant
Journal:  Circ Res       Date:  2010-03-19       Impact factor: 17.367

8.  Cardiac mesenchymal cells from diabetic mice are ineffective for cell therapy-mediated myocardial repair.

Authors:  Parul Mehra; Yiru Guo; Yibing Nong; Pawel Lorkiewicz; Marjan Nasr; Qianhong Li; Senthilkumar Muthusamy; James A Bradley; Aruni Bhatnagar; Marcin Wysoczynski; Roberto Bolli; Bradford G Hill
Journal:  Basic Res Cardiol       Date:  2018-10-23       Impact factor: 17.165

9.  Exercise-induced endothelial progenitor cell mobilization is attenuated in impaired glucose tolerance and type 2 diabetes.

Authors:  Andrew H Lutz; Jacob B Blumenthal; Rian Q Landers-Ramos; Steven J Prior
Journal:  J Appl Physiol (1985)       Date:  2016-05-19

10.  Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes.

Authors:  Gian Paolo Fadini; Elisa Boscaro; Saula de Kreutzenberg; Carlo Agostini; Florian Seeger; Stefanie Dimmeler; Andreas Zeiher; Antonio Tiengo; Angelo Avogaro
Journal:  Diabetes Care       Date:  2010-02-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.